amsacrine has been researched along with Cancer, Second Primary in 1 studies
Amsacrine: An aminoacridine derivative that intercalates into DNA and is used as an antineoplastic agent.
amsacrine : A sulfonamide that is N-phenylmethanesulfonamide substituted by a methoxy group at position 3 and an acridin-9-ylamino group at position 4. It exhibits antineoplastic activity.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Nully Brown, P | 1 |
| Hoffmann, T | 1 |
| Hansen, OP | 1 |
| Boesen, AM | 1 |
| Grønbaek, K | 1 |
| Hippe, E | 1 |
| Jensen, MK | 1 |
| Thorling, K | 1 |
| Storm, HH | 1 |
| Pedersen-Bjergaard, J | 1 |
1 trial available for amsacrine and Cancer, Second Primary
| Article | Year |
|---|---|
Long-term survival and development of secondary malignancies in patients with acute myeloid leukemia treated with aclarubicin or daunorubicin plus cytosine arabinoside followed by intensive consolidation chemotherapy in a Danish national phase III trial.
Topics: Aclarubicin; Acute Disease; Adolescent; Adult; Age Factors; Aged; Amsacrine; Antineoplastic Combined | 1997 |